Engineers Gate Manager’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-113,702
Closed -$152K 2619
2026
Q1
$152K Buy
113,702
+69,299
+156% +$138K ﹤0.01% 1965
2025
Q4
$109K Buy
+44,403
New +$193K ﹤0.01% 1908
2025
Q2
Sell
-22,717
Closed -$191K 2540
2025
Q1
$191K Sell
22,717
-10,827
-32% -$97.3K ﹤0.01% 1903
2024
Q4
$250K Buy
33,544
+9,545
+40% +$63.9K ﹤0.01% 1800
2024
Q3
$139K Buy
+23,999
New +$154K ﹤0.01% 1871
2023
Q3
Sell
-53,298
Closed -$1.36M 2082
2023
Q2
$1.36M Sell
53,298
-29,409
-36% -$759K 0.05% 530
2023
Q1
$2.08M Buy
82,707
+57,564
+229% +$1.35M 0.09% 308
2022
Q4
$578K Buy
+25,143
New +$579K 0.03% 797

Other funds holding TMCI

Engineers Gate Manager's TMCI Position: Q2 2026 in Review

Engineers Gate Manager sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 113,702 shares — an estimated $152K sold.

Engineers Gate Manager first reported a position in TMCI in Q4 2022 and held it in 8 quarters. The position peaked at $2.08M in Q1 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Engineers Gate Manager reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 113,702 Treace Medical Concepts shares in Q2 2026, an estimated $152K.
  • Engineers Gate Manager first reported a position in Treace Medical Concepts in Q4 2022 and held it in 8 quarters.
  • Engineers Gate Manager's Treace Medical Concepts position peaked at $2.08M in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.